G. Douglas Cole
Affiliations
- at Foghorn Therapeutics Inc. (FHTX), 2025-06-17
- at Sana Biotechnology Inc. (SANA), 2024-07-15
- at Sigilon Therapeutics Inc. (SGTX), 2023-08-11
- Director at Denali Therapeutics Inc. (DNLI), 2023-06-05
- at Quanterix Corp (QTRX), 2019-01-04
- Director at Editas Medicine Inc. (EDIT), 2017-08-21
- Director at Agios Pharmaceuticals Inc (AGIO), 2016-08-11
- Director at Receptos Inc. (RCPT), 2013-07-20
- Director at Tetraphase Pharmaceuticals Inc (TTPH), 2013-05-20
- Director at Aveo Pharmaceuticals Inc (AVEO), 2011-05-16
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| AVEO | $17.98 | 49,500 | $889,876.35 | 395,565 | 2011-05-16 | Filing |
| AVEO | $17.98 | 2,992 | $53,787.78 | 23,909 | 2011-05-16 | Filing |
| AVEO | $17.75 | 76,750 | $1,362,450.65 | 445,065 | 2011-05-13 | Filing |
| AVEO | $17.75 | 4,639 | $82,350.14 | 26,901 | 2011-05-13 | Filing |
| AVEO | $17.30 | 15,200 | $263,010.16 | 521,815 | 2011-05-12 | Filing |